Αxicabtagene ciloleucel is indicated for:
Irrespective of gender only Adults (18 - 65 years old)
Αxicabtagene ciloleucel is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.
For this indication, the medical literature mentions below treatments (click for details):
Irrespective of gender only Adults (18 - 65 years old)
Αxicabtagene ciloleucel is indicated for the treatment of adult patients with primary mediastinal large B-cell lymphoma (PMBCL), after two or more lines of systemic therapy.
For this indication, the medical literature mentions below treatments (click for details):